[Improvement of clinical symptoms and endoscopic features of reflux oesophagitis by polyvinyl-polypyrralidone (author's transl)].
D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D006801:Humans; D010919:Placebos; D011205:Povidone / Q000009:adverse effects / Q000627:therapeutic use*
D010919:Placebos; D011205:Povidone
Régression des symptômes cliniques et des lésions endoscopiques de l'oesophagite par reflux par le polyvinyl-polypyrralidone.